Davis Polk advised the representatives of the several underwriters in connection with the offering. General Mills executed its offering consisting of $500 million of its 2.250% notes...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Uniti Group Inc. on the offering. Uniti Group Inc. announced a Rule 144A and Regulation S offering of $700 million aggregate principal amount of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised MicroTech Medical, while Clifford Chance has advised the joint sponsors involved in the transaction. The Hangzhou-based firm offers diabetes therapy and manufactures medical...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Life Time, while Davis Polk advised the representatives of the several underwriters in connection with the offering. Life Time Group Holdings, Inc....
You must be a Standard 1 Year member to access this content.
Davis Polk advised Genesis Capital LLC and affiliates of Goldman Sachs on the transaction. New Residential Investment Corp. announced the acquisition of Genesis Capital and a related...
You must be a Standard 1 Year member to access this content.
Davis Polk advised XP Inc. on the transaction. Pinheiro Guimarães advised Jive Investments XP Inc. announced its acquisition of a minority stake in Jive Investments Consultoria...
You must be a Standard 1 Year member to access this content.
Davis Polk advised BofA Securities, Inc., as the sole underwriter on the deal. Kevin Glazer Irrevocable Exempt Family Trust and Edward S. Glazer Irrevocable Exempt Trust...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised China National Bluestar (Group) Co Ltd. and REC Solar Holdings AS on the transaction. Davis Polk advised Reliance New Energy Solar on the...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Lazard as financial adviser to Adamas Pharmaceuticals on the deal while Saul Ewing Arnstein & Lehr represented Supernus. Adamas Pharmaceuticals announced its $450 million...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Nuvei Corporation on the deal. Nuvei Corporation executed its initial U.S. public offering of 3,450,000 subordinate voting shares, including 450,000 subordinate voting shares...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in connection with the initial public offering. Enphys Acquisition Corp executed its initial public offering of 34,500,000 units including 4,500,000 units purchased pursuant...
You must be a Standard 1 Year member to access this content.
Davis Polk is advised Regions Bank on the transaction, while Kramer Levin advised Sabal. Regions Bank announced its acquisition of Sabal Capital Partners. The transaction is...
You must be a Standard 1 Year member to access this content.
